Gibril F - Search Results

1

X-chromosome loss of heterozygosity frequently occurs in gastrinomas and is correlated with aggressive tumor growth.

Chen YJ, Vortmeyer A, Zhuang Z, Gibril F, Jensen RT. Chen YJ, et al. Among authors: gibril f. Cancer. 2004 Apr 1;100(7):1379-87. doi: 10.1002/cncr.20104. Cancer. 2004. PMID: 15042671 Free article.

2

Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma.

Shojamanesh H, Gibril F, Louie A, Ojeaburu JV, Bashir S, Abou-Saif A, Jensen RT. Shojamanesh H, et al. Among authors: gibril f. Cancer. 2002 Jan 15;94(2):331-43. doi: 10.1002/cncr.10195. Cancer. 2002. PMID: 11900219 Free article.

3

Her-2/neu expression and gene amplification in gastrinomas: correlations with tumor biology, growth, and aggressiveness.

Goebel SU, Iwamoto M, Raffeld M, Gibril F, Hou W, Serrano J, Jensen RT. Goebel SU, et al. Among authors: gibril f. Cancer Res. 2002 Jul 1;62(13):3702-10. Cancer Res. 2002. PMID: 12097278

4

Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1.

Gibril F, Chen YJ, Schrump DS, Vortmeyer A, Zhuang Z, Lubensky IA, Reynolds JC, Louie A, Entsuah LK, Huang K, Asgharian B, Jensen RT. Gibril F, et al. J Clin Endocrinol Metab. 2003 Mar;88(3):1066-81. doi: 10.1210/jc.2002-021314. J Clin Endocrinol Metab. 2003. PMID: 12629087

5

Prospective study of the ability of serial measurements of serum chromogranin A and gastrin to detect changes in tumor burden in patients with gastrinomas.

Abou-Saif A, Gibril F, Ojeaburu JV, Bashir S, Entsuah LK, Asgharian B, Jensen RT. Abou-Saif A, et al. Among authors: gibril f. Cancer. 2003 Jul 15;98(2):249-61. doi: 10.1002/cncr.11473. Cancer. 2003. PMID: 12872342 Free article.

6

Meningiomas may be a component tumor of multiple endocrine neoplasia type 1.

Asgharian B, Chen YJ, Patronas NJ, Peghini PL, Reynolds JC, Vortmeyer A, Zhuang Z, Venzon DJ, Gibril F, Jensen RT. Asgharian B, et al. Among authors: gibril f. Clin Cancer Res. 2004 Feb 1;10(3):869-80. doi: 10.1158/1078-0432.ccr-0938-3. Clin Cancer Res. 2004. PMID: 14871962

7

Zollinger-Ellison syndrome revisited: diagnosis, biologic markers, associated inherited disorders, and acid hypersecretion.

Gibril F, Jensen RT. Gibril F, et al. Curr Gastroenterol Rep. 2004 Dec;6(6):454-63. doi: 10.1007/s11894-004-0067-5. Curr Gastroenterol Rep. 2004. PMID: 15527675 Review.

8

Advances in evaluation and management of gastrinoma in patients with Zollinger-Ellison syndrome.

Gibril F, Jensen RT. Gibril F, et al. Curr Gastroenterol Rep. 2005 May;7(2):114-21. doi: 10.1007/s11894-005-0049-2. Curr Gastroenterol Rep. 2005. PMID: 15802099 Review.

9

Growth of newly diagnosed, untreated metastatic gastrinomas and predictors of growth patterns.

Sutliff VE, Doppman JL, Gibril F, Venzon DJ, Yu F, Serrano J, Jensen RT. Sutliff VE, et al. Among authors: gibril f. J Clin Oncol. 1997 Jun;15(6):2420-31. doi: 10.1200/JCO.1997.15.6.2420. J Clin Oncol. 1997. PMID: 9196158 Clinical Trial.

10

Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas.

Goebel SU, Serrano J, Yu F, Gibril F, Venzon DJ, Jensen RT. Goebel SU, et al. Among authors: gibril f. Cancer. 1999 Apr 1;85(7):1470-83. Cancer. 1999. PMID: 10193936 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters